UPDATE 5-Pfizer boosts cancer drug roster with $14 bln Medivation deal
 

UPDATE 5-Pfizer boosts cancer drug roster with $14 bln Medivation deal
Aug 22 (Reuters) - Pfizer Inc, beating out numerousother bidders, said it agreed to buy U.S. cancer drug companyMedivation Inc for $14 billion in cash, adding itsblockbuster prostate cancer drug Xtandi to the company's growingoncology roster.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...xM:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...xM:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/fWaiffJtTcE